Am Fam Physician. 2010;82(12):1471-1478
A more recent article on secondary hypertension is available.
Author disclosure: Nothing to disclose.
Secondary hypertension is a type of hypertension with an underlying, potentially correctable cause. A secondary etiology may be suggested by symptoms (e.g., flushing and sweating suggestive of pheochromocytoma), examination findings (e.g., a renal bruit suggestive of renal artery stenosis), or laboratory abnormalities (e.g., hypokalemia suggestive of aldosteronism). Secondary hypertension also should be considered in patients with resistant hypertension, and early or late onset of hypertension. The prevalence of secondary hypertension and the most common etiologies vary by age group. Approximately 5 to 10 percent of adults with hypertension have a secondary cause. In young adults, particularly women, renal artery stenosis caused by fibromuscular dysplasia is one of the most common secondary etiologies. Fibromuscular dysplasia can be detected by abdominal magnetic resonance imaging or computed tomography. These same imaging modalities can be used to detect atherosclerotic renal artery stenosis, a major cause of secondary hypertension in older adults. In middle-aged adults, aldosteronism is the most common secondary cause of hypertension, and the recommended initial diagnostic test is an aldosterone/renin ratio. Up to 85 percent of children with hypertension have an identifiable cause, most often renal parenchymal disease. Therefore, all children with confirmed hypertension should have an evaluation for an underlying etiology that includes renal ultrasonography.
In the United States, one in three adults has hypertension.1 Most of these patients have no clear etiology and are classified as having essential hypertension. However, 5 to 10 percent have secondary hypertension, in which an underlying, potentially correctable etiology can be identified. 2,3 Among children with hypertension, secondary causes are much more common.4 Whenever a patient is diagnosed with hypertension, one purpose of the initial assessment (i.e., history, physical examination, and basic laboratory testing) is to exclude possible secondary causes (Table 1).4–27 Indications for further investigation into a possible secondary etiology in the absence of suggestive signs and symptoms include resistant hypertension (defined as elevated blood pressure despite patient adherence to optimal dosages of three antihypertensive agents, including a diuretic), early or late onset of hypertension, a severe or accelerated course, or specific drug intolerances.5,28
Clinical recommendation | Evidence rating | References |
---|---|---|
In the absence of clinical signs to suggest possible secondary hypertension in adults, indications for further evaluation include resistant hypertension and early, late, or rapid onset of high blood pressure. | C | 5 |
All preadolescent children with hypertension should be evaluated for possible secondary causes. | C | 4 |
Young adults thought to have secondary hypertension should be assessed for fibromuscular dysplasia of the renal artery. | C | 7, 8 |
The aldosterone/renin ratio is the best initial test to determine whether a patient with hypertension should have further evaluation for aldosteronism. | C | 20, 25 |
Obstructive sleep apnea can be a secondary cause of or contribute to hypertension. | C | 38 |
Signs/symptoms | Possible secondary hypertension cause | Diagnostic test options |
---|---|---|
Arm to leg systolic blood pressure difference > 20 mm Hg Delayed or absent femoral pulses Murmur | Coarctation of the aorta | Magnetic resonance imaging (adults) Transthoracic echocardiography (children) |
Increase in serum creatinine concentration (≥ 0.5 to 1 mg per dL [44.20 to 88.40 μmol per L]) after starting angiotensin-converting enzyme inhibitor or angiotensin receptor blocker Renal bruit | Renal artery stenosis | Computed tomography angiography Doppler ultrasonography of renal arteries Magnetic resonance imaging with gadolinium contrast media |
Bradycardia/tachycardia Cold/heat intolerance Constipation/diarrhea Irregular, heavy, or absent menstrual cycle | Thyroid disorders | Thyroid-stimulating hormone |
Hypokalemia | Aldosteronism | Renin and aldosterone levels to calculate aldosterone/renin ratio |
Apneic events during sleep Daytime sleepiness Snoring | Obstructive sleep apnea | Polysomnography (sleep study) Sleep Apnea Clinical Score with nighttime pulse oximetry |
Flushing Headaches Labile blood pressures Orthostatic hypotension Palpitations Sweating Syncope | Pheochromocytoma | 24-hour urinary fractionated metanephrines Plasma free metanephrines |
Buffalo hump Central obesity Moon facies Striae | Cushing syndrome | 24-hour urinary cortisol Late-night salivary cortisol Low-dose dexamethasone suppression |
General Approach to the Patient
First, the physician should confirm that the patient's blood pressure has been accurately measured using correct positioning with an appropriately sized cuff.5 Ambulatory blood pressure monitoring can be useful to rule out white coat hypertension, if suspected.28 It is also important to review the patient's diet and medication use for other potential causes of elevated blood pressure. Excessive consumption of sodium, licorice, or alcohol is known to increase blood pressure.29 Many drugs affect blood pressure (Table 2),5,28 and a trial period off of a potentially offending medication may be all that is needed to reduce blood pressure.28 If these potential contributors to hypertension have been excluded and concern for secondary hypertension remains, the physician can investigate for potential physiologic causes.
Drug class | Common examples |
---|---|
Estrogen | Oral contraceptives |
Herbal | Ephedra, ginseng, ma huang |
Illicit | Amphetamines, cocaine |
Nonsteroidal anti-inflammatory | Cyclooxygenase-2 inhibitors, ibuprofen, naproxen (Naprosyn) |
Psychiatric | Buspirone (Buspar), carbamazepine (Tegretol), clozapine (Clozaril), fluoxetine (Prozac), lithium, tricyclic antidepressants |
Steroid | Methylprednisolone (Depo-Medrol), prednisone |
Sympathomimetic | Decongestants, diet pills |
The most common etiologies in children, in whom 70 to 85 percent of cases of hypertension have a secondary cause,4,30,31 are different from those in older persons32; therefore, an age-based approach to the differential diagnosis is recommended. Blood pressure cutoffs in children are based on sex, age, and height percentile4; charts with appropriate blood pressure ranges for children can be found at http://www.pediatrichypertension.org/calcs.asp.
Table 3 summarizes the most common causes of secondary hypertension by age,2,3,30–34 and Figure 1 outlines a suggested approach to the initial evaluation of patients with suspected secondary hypertension. Physicians must remember that these are not absolute categories; there may be overlap of causes between age groups. The remainder of our article discusses the use of specific strategies for patients in different age groups.
Age groups | Percentage of hypertension with an underlying cause | Most common etiologies† |
---|---|---|
Children (birth to 12 years) | 70 to 85 | Renal parenchymal disease |
Coarctation of the aorta | ||
Adolescents (12 to 18 years) | 10 to 15 | Renal parenchymal disease |
Coarctation of the aorta | ||
Young adults (19 to 39 years) | 5 | Thyroid dysfunction |
Fibromuscular dysplasia | ||
Renal parenchymal disease | ||
Middle-aged adults (40 to 64 years) | 8 to 12 | Aldosteronism |
Thyroid dysfunction | ||
Obstructive sleep apnea | ||
Cushing syndrome | ||
Pheochromocytoma | ||
Older adults (65 years and older) | 17 | Atherosclerotic renal artery stenosis |
Renal failure | ||
Hypothyroidism |
Children and Adolescents (Birth to 18 Years of Age)
RENAL PARENCHYMAL DISEASE
Renal parenchymal disease is the most common cause of hypertension in preadolescent children.4,30 In this age group, such renal pathology includes glomerulonephritis, congenital abnormalities, and reflux nephropathy. Sometimes the resulting hypertension is not apparent until young adulthood,35 so this etiology should still be considered in the differential diagnosis outside of childhood. Initial evaluation for suspected renal parenchymal disease should include measurement of blood urea nitrogen and creatinine levels, a urinalysis, urine culture, and renal ultrasonography.
COARCTATION OF THE AORTA
Coarctation of the aorta is the second most common cause of hypertension in children, and is two to five times more common in boys.36 Although coarctation may present acutely in the neonate as congestive heart failure, it is typically diagnosed around five years of age with the onset of hypertension or a cardiac murmur.37 Rarely, mild cases of coarctation have occurred in adults. Discrepancies between bilateral brachial, or brachial and femoral blood pressures, suggest coarctation (Table 1).4–27 In younger patients, chest radiography may be nonspecific, whereas in adults the classic “three” sign or rib notching may be evident. Transthoracic echocardiography is sufficient for diagnosis in children, given their smaller body habitus, and is useful to concurrently evaluate for left ventricular hypertrophy.4 However, magnetic resonance imaging (MRI) is increasingly common and is the preferred imaging method in adults.6
Young Adults (19 to 39 Years of Age)
RENAL ARTERY STENOSIS CAUSED BY FIBROMUSCULAR DYSPLASIA
Fibromuscular dysplasia is a vascular disorder of unknown etiology that has a predilection for the renal arteries, causing narrowing that leads to decreased renal perfusion. In young adults, particularly women, fibromuscular dysplasia is one of the most common causes of secondary hypertension.7 Patients with renal artery stenosis may have an audible high-pitched holosystolic renal artery bruit. Compared with patients without such a finding, those in whom a renal artery bruit is detected have a relative risk of approximately 5.0 for renal artery stenosis8; these patients should all have further testing.
Although angiography is the diagnostic standard for detecting renal artery stenosis, it is invasive and should not be used as an initial diagnostic test. MRI with gadolinium contrast media and computed tomography (CT) angiography are equally accurate in visualizing stenosis9–11 (Table 49,10,12–18 ). However, MRI does not use radiation and can determine the physiologic degree of stenosis. MRI can also be used for patients with poor renal function, particularly when used without gadolinium, although with a slight decrease in sensitivity and specificity.11 If MRI and CT angiography are contraindicated, renal Doppler can be used; Doppler provides useful information regarding blood flow, but its accuracy is affected by body habitus and operator skill.12 Because captopril (Capoten)-augmented renography has poor sensitivity and specificity, which translate into likelihood ratios close to 1.0, it is no longer considered a good first-line test12 (Table 49,10,12–18 ).
Potential secondary cause and diagnostic tests | Positive likelihood ratio | Negative likelihood ratio |
---|---|---|
Aldosteronism | ||
Aldosterone/renin ratio > 20* | 4.6 | 0.27 |
Aldosterone/renin ratio > 30* | 28.0 | 0.16 |
Coarctation of the aorta | ||
Echocardiography | 47.0 | 0.06 |
Cushing syndrome | ||
24-hour urinary free cortisol | 10.6 | 0.16 |
Late-night salivary cortisol | 8.8 | 0.07 |
Low-dose dexamethasone suppression | 11.6 | 0.09 |
Obstructive sleep apnea | ||
Overnight polysomnography† | — | — |
Sleep Apnea Clinical Score with nighttime pulse oximetry | 5.2 | 0.25 |
Pheochromocytoma | ||
24-hour urinary total metanephrines | 8.0 | 0.13 |
Plasma free metanephrines | 5.5 | 0.01 |
Renal artery stenosis | ||
Captopril (Capoten)-augmented renography | 1.4 | 0.76 |
Computed tomography angiography | 13.4 | 0.06 |
Magnetic resonance imaging with gadolinium contrast media | 13.9 | 0.03 |
Renal parenchymal disease | ||
Renal ultrasonography | 2.9 | 0.32 |
THYROID DYSFUNCTION
Thyroid hormone affects cardiac output and systemic vascular resistance, which in turn affect blood pressure. Hypothyroidism can cause an elevation in diastolic blood pressure, whereas hyperthyroidism can cause an isolated elevation of systolic blood pressure, leading to a widened pulse pressure.19 Although hypothyroidism is one of the more common secondary causes of hypertension in young adults, there is actually an increased incidence of hypothyroidism with age, peaking in a patient's 60s.32 In contrast, hyperthyroidism is significantly associated with elevated blood pressures in 20- to 50-year-olds.33 Because thyroid dysfunction occurs across multiple age groups, testing for it should be considered if there are any suggestive symptoms. Thyroid-stimulating hormone is a sensitive marker used for initial diagnosis of either condition.
Middle-Aged Adults (40 to 64 Years of Age)
ALDOSTERONISM
Primary aldosteronism, also referred to as hyperaldosteronism, is actually a group of conditions, including aldosterone-producing adenomas and bilateral idiopathic hyperaldosteronism. Non–medication-induced hypokalemia should lead the physician to suspect aldosteronism, although this abnormality occurs in only 30 percent of patients.20 Aldosteronism was once considered to be rare, but with more careful investigations, the incidence among patients with hypertension was found to be approximately 6 percent.21 Aldosteronism affects 10 to 20 percent of patients with resistant hypertension, making it the most common cause of secondary hypertension in this subgroup.22,23
The best initial test for aldosteronism is measurement of the aldosterone/renin ratio.20,25 It is the most sensitive test to detect primary aldosteronism, because approximately 25 percent of persons with the condition have normal aldosterone levels.21,24 Ideally, aldosterone and renin levels should be measured in the morning at least two hours after waking and in the upright position. 25 If the aldosterone/renin ratio is above 20 (when plasma aldosterone is reported in ng per dL and plasma renin activity in ng per mL per hour), and is accompanied by an aldosterone level above 15 ng per dL (416.10 pmol per L), the patient should be referred to an endocrinologist for confirmatory testing with one of several salt suppression tests.25 CT may be able to detect larger aldosteronomas, but may not detect microadenomas or hyperplasia and is, therefore, not reliable.
OBSTRUCTIVE SLEEP APNEA
Obstructive sleep apnea is a notable cause of secondary hypertension,38 particularly in 40- to 59-year-olds, but less so in those 60 years and older.34 The standard diagnostic test is polysomnography, but clinical assessment tools (e.g., Epworth Sleepiness Scale, Sleep Apnea Clinical Score) with nighttime pulse oximetry may be sufficient for the diagnosis of moderate to severe obstructive sleep apnea, particularly if cost and availability are limiting.26,39 In patients with obstructive sleep apnea, the normal variation in blood pressure over 24 hours is impaired and it may be beneficial to perform ambulatory blood pressure monitoring on these patients to fully evaluate their circadian pressures.40
PHEOCHROMOCYTOMA
Pheochromocytomas are rare tumors responsible for approximately 0.5 percent of cases of secondary hypertension.2,3,32 Patients typically present between 30 and 60 years of age. Testing for a pheochromocytoma is not part of the initial evaluation for secondary hypertension unless specific symptoms are suggestive (Table 1).4–27 Diagnosis is important because of the cardiovascular sequelae, and because the hypertension is largely reversible with surgery. Testing can be done by measuring metanephrines in a 24-hour urine sample, but measurement of plasma free metanephrines is easier for the patient and has a negative likelihood ratio close to zero, making it a good test to rule out the disorder 13 (Table 49,10,12–18 ).
CUSHING SYNDROME
Most presentations of Cushing syndrome (hypercortisolism) are iatrogenic from prescribed corticosteroids, which again highlights the importance of reviewing the patient's medications. However, only 20 percent of patients with iatrogenic Cushing syndrome have hypertension.27 In contrast, tumors causing Cushing syndrome are rare (two to five cases per 1 million persons per year), but 80 percent or more of these patients will develop hypertension.27 Given the low frequency of Cushing syndrome, testing should be done only if there are suggestive features (Table 14–27 ) or after other possible causes have been ruled out. Options for initial testing include 24-hour urinary free cortisol, low-dose dexamethasone suppression, or late-night salivary cortisol tests, although ultimately these patients should be referred to an endocrinologist for a complete evaluation.14
Older Adults (65 Years and Older)
RENAL ARTERY STENOSIS CAUSED BY ATHEROSCLEROSIS
Renal artery stenosis secondary to atherosclerotic disease affects older adults. It should be suspected in those who develop hypertension after 50 years of age, have known atherosclerosis elsewhere, have unexplained renal insufficiency, or have a rapid deterioration in kidney function (i.e., an increase in the serum creatinine level of at least 0.5 to 1 mg per dL [44.20 to 88.40 μmol per L]) when started on an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker.5,41 The presence of a renal artery bruit and the recommended imaging studies are the same as for fibromuscular dysplasia described earlier. However, a recent randomized controlled trial found that medical management was as effective as revascularization in patients whose physician believed they did not have a clear indication for revascularization, with similar rates of blood pressure control and cardiovascular deaths, and without the associated complications of surgery.42 Thus, revascularization is not required for all patients.
RENAL FAILURE
Hypertension can be a major cause of renal parenchymal damage, particularly in older adults, which in turn leads to worsening hypertension. Alternatively, renal damage from another process, such as diabetes mellitus, can result in hypertension. Evaluation for possible chronic renal failure should include calculating the estimated glomerular filtration rate and obtaining a urinalysis to assess for albuminuria. Renal ultrasonography may also be helpful in determining the cause and chronicity of the renal failure.43